What's in a Nicotine Pouch?

The ingredient list is shorter than you might expect, and each component has a specific function.

Nicotine pouches have a short ingredient list, and each component is there for a reason. Understanding what is in the pouch and why helps you evaluate claims about safety, because most of the risk questions come down to specific ingredients and what they do at the tissue level over time. The list is simpler than you might expect from a product that generates this many health questions.

Nicotine

The active ingredient and the reason the product exists. In nicotine pouches, nicotine is either extracted from tobacco plants or synthesized in a laboratory. Pharmacologically, there is no difference: synthetic nicotine and tobacco-derived nicotine are the same molecule with the same structure and the same effects on the brain’s nicotinic acetylcholine receptors [5]. The distinction matters for regulatory classification, because synthetic nicotine was initially outside FDA tobacco authority until the 2022 Consolidated Appropriations Act brought it under the same regulatory umbrella [4]. For your body, the source makes no difference.

Pouch strengths are typically labeled in milligrams of total nicotine content, ranging from about 2 mg to 12 mg or higher depending on the brand and market. The amount of nicotine that actually reaches the bloodstream is lower than the labeled amount, because absorption through the oral mucosa is not 100% efficient. Studies comparing nicotine pouches to snus have found that plasma nicotine levels from pouches reach lower peaks and rise more slowly than those from snus at comparable labeled strengths, which is partly a function of the pouch formulation and partly a function of how quickly the nicotine is released from the filler matrix [2].

This pharmacokinetic profile matters for understanding dependence. A slower, lower nicotine peak means a less intense rush than a cigarette, but the steady-state nicotine levels achieved by continuous pouch use, one after another throughout the day, can be substantial. The dependence potential is driven not by the peak of any single dose but by the chronic receptor exposure that sustained use creates.

pH adjusters

This is the ingredient that makes the pouch work as a nicotine delivery system, and it is the one that most people have never heard of. Nicotine exists in two chemical forms: its protonated form, also called nicotine salt, which is stable but poorly absorbed through mucous membranes, and its freebase form, which crosses cell membranes efficiently and enters the bloodstream through the oral mucosa [5].

The pH adjusters, usually sodium carbonate or sodium bicarbonate, raise the pH of the moist pouch environment to an alkaline level, typically above pH 8. This shifts the nicotine toward its freebase form, making it bioavailable for absorption through the tissue of the gum and inner lip [1]. Without this pH adjustment, you could hold a pouch in your mouth and absorb very little nicotine. The pH adjusters are what turn a pouch of flavored filler into a nicotine delivery system.

This is the same principle used in Scandinavian snus, which has employed alkaline salts to enhance nicotine delivery for well over a century. It is also, in reverse, the principle behind nicotine salt e-liquids used in pod-style vapes: those keep the pH lower, so the nicotine stays in its protonated form, allowing higher concentrations without the harshness that freebase nicotine causes in the throat.

The pH adjusters are also the reason nicotine pouches cause a tingling or burning sensation at the gum line, especially noticeable with higher-strength pouches. The alkaline environment irritates the oral mucosa mildly. This is simultaneously the delivery mechanism and the most common side effect. The irritation is not a malfunction; it is a direct consequence of the chemistry that makes the product work.

Whether chronic exposure to an alkaline microenvironment at the gum line contributes to the gum recession that some long-term users report is plausible on mechanistic grounds but has not been isolated as a cause in clinical studies. The alkaline pH, the nicotine’s vasoconstrictive effect on gum tissue, and the mechanical pressure of the pouch itself all contribute to the local tissue effects, and separating their individual contributions would require studies that have not been conducted.

Fillers

The bulk of the pouch is a plant-based filler, typically microcrystalline cellulose, hydroxypropyl cellulose, or another food-grade plant fiber [1]. This gives the pouch its physical structure, its shape and texture, and provides a matrix to hold the nicotine, flavorings, and pH adjusters in place. The filler has no pharmacological function. It is there to make the pouch a physical object that sits comfortably between the gum and lip and releases its contents gradually rather than all at once.

Different brands use different filler compositions, which is why pouches from different manufacturers can feel quite different in the mouth: some are softer and thinner, others are denser and more structured. The filler choice affects the release kinetics of the nicotine, which is why two pouches with the same labeled nicotine content can feel different in terms of how quickly the nicotine hits and how long the effect lasts.

Flavorings and sweeteners

Nicotine pouches come in a range of flavors: mint, wintergreen, citrus, coffee, berry, and others. The flavorings are food-grade compounds generally recognized as safe for oral ingestion by the FDA [1]. The sweeteners, often sucralose or acesulfame potassium, serve a specific purpose: they mask the bitterness of nicotine, which in its freebase form is unpleasant enough that unflavored pouches would be a difficult product to use.

One open question is whether repeated, prolonged oral mucosal exposure to these flavorings at the concentrations used in pouches carries any long-term risk. The GRAS designation covers oral ingestion, meaning swallowing the compound and having it processed by the digestive system and liver. It does not specifically address continuous direct contact with gum tissue over years. This is not an accusation; it is an observation about the scope of the existing safety data. The flavorings are safe to eat. Whether they are safe to hold against the same patch of gum tissue for hours a day, every day, for years, is a question that the existing safety framework was not designed to answer and that pouch-specific data has not yet addressed.

The flavoring question is not unique to nicotine pouches. Similar questions have been raised about flavorings in vape liquids, where compounds that are safe to ingest proved to cause lung damage when inhaled. The exposure route matters, and the oral mucosal route is different from both ingestion and inhalation. But the general principle holds: safe in one route of administration does not automatically mean safe in another.

Moisture agents

A humectant, often propylene glycol or vegetable glycerin, keeps the pouch moist and helps with nicotine release from the filler matrix. Both are food-grade compounds widely used in consumer products ranging from toothpaste to baked goods. In the concentrations present in a nicotine pouch, they are not considered a health concern based on available toxicological data [1]. They serve a functional purpose: a dry pouch releases nicotine poorly and feels unpleasant in the mouth.

What is absent

Nicotine pouches do not contain tobacco leaf. This is the primary distinction between pouches and other oral nicotine products like snus, dipping tobacco, and chewing tobacco. The absence of tobacco leaf means the absence of the plant matter that contributes to the higher TSNA levels in those products, because TSNAs form partly during the curing and processing of tobacco leaf.

They do not produce combustion products. There is no tar, no carbon monoxide, no particulate matter, none of the 7,000-plus chemicals generated by burning tobacco. This removes the mechanism responsible for lung cancer, COPD, and the majority of the cardiovascular disease burden associated with cigarettes.

They do, however, contain trace levels of tobacco-specific nitrosamines when the nicotine is tobacco-derived, at levels substantially below those found in snus or chewing tobacco [3]. The independent analysis from the University of Minnesota found these trace TSNA levels in commercially available US-market pouches. Whether these trace levels are biologically significant over decades of use is one of the open questions about the product. Products using synthetic nicotine may avoid TSNAs entirely, though comprehensive independent testing of synthetic-nicotine pouches is limited.

The interaction question

Each individual ingredient in a nicotine pouch has a food-safety profile. Cellulose is food-grade. Sodium carbonate is food-grade. The flavorings are GRAS. Propylene glycol is widely used. Nicotine is an established drug with known pharmacology. What does not have a safety profile is the specific combination of these ingredients, at the concentrations used, in continuous contact with oral tissue, under the use patterns typical of daily pouch users. This is not unusual for a new product category: the interaction data comes after the individual component data, and it requires time.

The alkaline pH that makes nicotine absorption possible also changes the local tissue environment. The nicotine that gets absorbed constricts blood vessels in the gum tissue. The flavoring compounds contact the same tissue. The filler sits against it for hours. Whether these simultaneous exposures have effects that none of them would produce individually is an open question, and it is the kind of question that typically takes years of clinical observation to answer.

What remains unknown

The long-term effects of the specific combination of ingredients in nicotine pouches, at the concentrations used, with the use patterns typical of daily pouch users, have not been studied. The oral tissue effects of chronic alkaline exposure at the pouch site have not been characterized beyond short-term observations. The flavorings have not been evaluated for long-term mucosal safety. The interaction between pH adjustment, nicotine vasoconstriction, and mechanical pressure from the pouch on gum health is not well-understood. This is not alarming per se; it is the expected state of knowledge for a product that has been on the market for fewer than ten years. But it is the state of knowledge, and treating these gaps as settled is not more honest than treating them as cause for alarm.

If you have questions about nicotine use and your health, speak with a doctor or pharmacist. The Quitline (1-800-QUIT-NOW) can help with quitting strategies.

Frequently asked questions

Do nicotine pouches contain tobacco?

No. They contain nicotine, which may be synthetic or extracted from tobacco, but they do not contain tobacco leaf. This distinguishes them from snus and chewing tobacco.

What are the pH adjusters in nicotine pouches?

Typically sodium carbonate or sodium bicarbonate. They raise the pH of the pouch environment, converting nicotine to its freebase form, which is absorbed more efficiently through the oral mucosa. This is the same principle used in Scandinavian snus.

Are nicotine pouch flavorings safe?

The flavorings used are generally recognized as safe (GRAS) for oral consumption by the FDA. Long-term effects of repeated oral mucosal exposure to these flavorings at the concentrations used in pouches have not been studied specifically.

Is synthetic nicotine different from tobacco-derived nicotine?

Pharmacologically, no. Synthetic nicotine and tobacco-derived nicotine are the same molecule. The distinction matters for regulatory purposes but not for how the nicotine affects your body.

Sources and further reading

  1. Azzopardi et al. — Chemical characterisation of tobacco-free 'modern' oral nicotine pouches

    Food and Chemical Toxicology, 2022. Compositional analysis of multiple nicotine pouch brands. BAT-funded. DOI: 10.1016/j.fct.2022.112713

  2. Lunell & Curvall — Nicotine delivery and subjective effects of Swedish snus and nicotine pouches

    Regulatory Toxicology and Pharmacology, 2021. Pharmacokinetics comparing pouches and snus, n=24. Swedish Match-funded. DOI: 10.1016/j.yrtph.2021.104965

  3. Stepanov et al. — Tobacco-specific nitrosamines in oral nicotine pouches

    Regulatory Toxicology and Pharmacology, 2022. TSNA analysis of US-market pouches. Independent (UMN). DOI: 10.1016/j.yrtph.2022.105270

  4. FDA — Premarket Tobacco Product Applications for Tobacco-Derived Nicotine Products

    FDA guidance on regulatory classification of nicotine products, including synthetic nicotine reclassification under the 2022 Consolidated Appropriations Act.

  5. Benowitz — Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics

    Annual Review of Pharmacology and Toxicology, 2009. Review of nicotine chemistry and absorption mechanisms. DOI: 10.1146/annurev.pharmtox.49.070308.120627

Sources checked June 1, 2025. This is an editorial summary, not a systematic review or individual advice.

Get new articles by email

New articles from Pouch Free, sent to your inbox. Unsubscribe at any time.

Related articles

Nicotine Pouches and Exercise

How nicotine pouches interact with exercise, what happens to heart rate and blood pressure when you combine the two, whether nicotine affects athletic performance, and what the risks are.

Zyn vs. Snus

A comparison of nicotine pouches (Zyn) and Swedish snus, covering ingredients, nicotine delivery, toxicant exposure, and what the long-term Swedish data tells us.

Nicotine Pouch Tolerance

How tolerance to nicotine pouches develops, why the same strength stops feeling the same, the neuroscience behind receptor upregulation, and why tolerance is the engine of dependence.